Skip to main content
ARS Home » Plains Area » Manhattan, Kansas » Center for Grain and Animal Health Research » ABADRU » People » Stacey Scroggs

Stacey Scroggs

Research Microbiologist
 /ARSUserFiles/57240/Stacey.jpg    

Dr. Stacey Scroggs
Research Microbiologist

USDA-ARS-CGAHR-ABADRU
ATTN: Stacey Scroggs
1515 College Ave.
Manhattan, KS 66502

stacey.scroggs@usda.gov
Telephone: 785.776.2702


EDUCATION

B.S., Biology, University of New Mexico

M.P.H., Epidemiology, Emory University

Ph.D., Biology, New Mexico State University


RESEARCH INTERESTS

Dr. Stacey Scroggs is a Research Microbiologist with the USDA-ARS in the Arthropod-Borne Animal Disease Research Unit of the Center for Animal Health and Gain Research in Manhattan, KS. Stacey was a post-doctoral fellow at the NIH's Rocky Mountain Laboratories in Hamilton, MT where she studied the persistence of tick transmitted Powassan and deer tick viruses. Stacey's current research focuses on midge transmitted viruses that cause disease in livestock, such as vesicular stomatitis virus, blue tongue virus, and epizootic hemorrhagic fever virus. She is specifically interested in studying the vector virus interactions and within host evolutionary dynamics of viruses transmitted by biting midges with the goal of better understanding virus emergence, adaptation, and evolution.  

Google Scholar    ORCID     LinkedIn


RECENT PUBLICATIONS
  

Scroggs SLP, Offerdahl DK, Flather DP, Morris CN, Kendall BL, Broekel R, Beare P, Bloom M E. Fluoroquinolone antibiotics exhibit low antiviral activity against SARS-CoV-2 and MERS-CoV. Viruses 2021b, 13, 8. doi: 10.3390/v1301000

  

Scroggs SLP, Gass J, Chinnasamy R, Widen SG, Azar SR, Arterburn JB, Vasilakis N, Hanley KA. Evolution of resistance to fluoroquinolones by dengue virus 4 provides insight into mechanism of action and consequences for viral fitness. Virology 2021a 552, 94-106. doi: 10.1016/j.virol.2020.09.004

    

Interrante JD, Scroggs SLP, Hogue CJ, Friedman JM, Reefhius J, Jann MW, Broussard CS. Prescription opioid use during pregnancy and risk for preterm birth or low birthweight. Journal of Opioid  Management 2021 May 1;17(3):215-225. doi: 10.5055/jom.2021.0632

    

Scroggs SLP, Andrade CA, Chinnasamy R, Azar SR, Schirtzinger EE, Garcia EI, Arterburn JB, Hanley KA, Rossi SL. Old drug new tricks: Efficacy of fluoroquinolones to suppress replication of flaviviruses. Viruses 2020, 12, 1022. doi: 10.3390/v12091022

    

Scroggs SLP, Grubaugh ND, Sena JA, Sundararajan A, Schilkey FD, Smith D, Ebel GD, Hanley KA. Endless forms: within-host variation in the structure of the West Nile virus RNA genome during serial passage in bird hosts. mShere, 2019, 4:e00291-19. doi: 10.1128/mSphere.00291-19.

    

Peters Scroggs, SL, Lind JN, Humphrey JR, Friedman JM, Honein MA, Tassinari MS, Moore CA, Mathis LL, Broussard CS. Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011. Pharmacoepidemiology and Drug Safety. 2013 22:324–328. doi: 10.1002/pds.3410.

    

Gibbs C, Wendt A, Peters Scroggs S, Hogue C. The impact of early age at first childbirth on maternal and infant health. Paediatric and Perinatal Epidemiology. 2012 26(S1):259-284. doi: 10.1111/j.1365-3016.2012.01290.x

    

Wendt A, Gibbs C, Peters Scroggs S, Hogue C. The impact of increasing inter-pregnancy intervals on maternal and infant health. Paediatric and Perinatal Epidemiology. 2012 26(S1):239-258. doi: 10.1111/j.1365-3016.2012.01285.x